Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Ethereum (ETH) Testing Key Support — Will This Bullish Setup Trigger a Bounce Back?

Ethereum (ETH) Testing Key Support — Will This Bullish Setup Trigger a Bounce Back?

CoinsProbeCoinsProbe2025/10/08 10:45
By:Nilesh Hembade

The cryptocurrency market is experiencing a notable retracement today after a strong bullish run that recently pushed Bitcoin (BTC) to a new all-time high of $126,000, before sliding to around $121,000. Ethereum (ETH), meanwhile, has dropped over 5%, falling from its 24-hour high of $4,755 to around $4,445.

However, despite the pullback, ETH’s price action remains technically significant — as it is currently testing a key support level that could decide whether the next move is a rebound or a deeper correction.

Ethereum (ETH) Testing Key Support — Will This Bullish Setup Trigger a Bounce Back? image 0 Source: Coinmarketcap

Power of 3 Pattern in Play

On the daily chart, Ethereum’s price structure is following the three-phase Power of 3 (PO3) pattern — a common setup seen before major breakouts.

Accumulation Phase

Throughout August, ETH traded sideways between $4,750 resistance and $4,215 support, signaling accumulation by institutional players as the market consolidated.

Manipulation Phase

On September 22, ETH dipped below the $4,215 range, sliding to $3,832 before rebounding sharply. This move marked the manipulation phase, where a false breakdown typically shakes out weak hands and traps shorts before the next leg higher.

Ethereum (ETH) Testing Key Support — Will This Bullish Setup Trigger a Bounce Back? image 1 Ethereum (ETH) Daily Chart/Coinsprobe (Source: Tradingview)

Expansion Phase

Following the rebound, ETH reclaimed its previous range near $4,215, entering the expansion phase. The token then rallied toward the $4,752 resistance — the upper boundary of its accumulation zone — before facing rejection. This pullback has now brought ETH back to test its 50-day moving average (MA) near $4,406, a level that could act as a crucial pivot point for the next move.

What’s Next for ETH?

If buyers manage to defend this 50-day MA support, a bounce from the current zone could set the stage for a break above $4,750, confirming a PO3 breakout. In such a scenario, ETH could rally toward its next technical target around $5,818, reigniting bullish momentum across the broader altcoin market.

However, failure to hold this level could push ETH back toward $4,215, delaying the breakout structure.

For now, traders and analysts are watching closely to see if Ethereum can maintain strength above the $4,400 region — a successful defense here could very well mark the start of the next leg higher.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Anthropic files for IPO: lost $4.2 billion last year, revenue grew 12x to $4.6 billion, risk section warns of "threats to human survival"

Anthropic's IPO prospectus reveals that its spending on computing power and infrastructure will reach $7.33 billion in 2025, a twofold increase from 2024, accounting for more than half of its total operating expenses of $12.65 billion. The company plans to continue investing over $500 billion in the future. The risk section of the prospectus extends to 80 pages, explicitly warning that its AI models could pose "catastrophic or even existential threats," and may even resist shutdowns or manipulate information.

华尔街见闻•2026/09/29 01:01

Meta shocks Wall Street by hiring MongoDB CEO and makes a high-profile entry into enterprise AI business

Meta has established an enterprise AI division called "Meta Enterprise Platform," which Mark Zuckerberg described as "the next important pillar." MongoDB CEO CJ Desai has been recruited to lead it. Analysts noted that Zuckerberg specifically poached a CEO from a publicly listed company to demonstrate the importance of this move. Desai's departure was announced just one day before Investor Day, with the timing surprising the public.

华尔街见闻•2026/09/29 00:51

AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose

This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.

华尔街见闻•2026/09/29 00:26